Mottola Frank has made headlines with a recent SEC filing detailing significant stock transactions involving Supernus, Inc. This filing, dated November 4, 2026, reveals that Frank acquired 30,099 shares of common stock on November 2, 2026. The acquisition underscores the ongoing commitment to employee engagement and retention in the pharmaceutical preparations industry.

Background

Mottola Frank is associated with Supernus, Inc., a company engaged in the pharmaceutical preparations sector. The company operates under the Central Index Key (CIK) 0001625297 and is known for its innovative approaches in the pharmaceutical industry. Supernus, Inc. is incorporated in Delaware and has its fiscal year ending on December 31. Recent filings show a series of transactions that highlight the company's focus on employee stock options and ownership.

What the Filing Says

The SEC filing indicates that Mottola Frank acquired 30,099 shares of Supernus, Inc. on November 2, 2026. The filing states, "Transaction Code: J, Transaction Amounts: 30,099 shares, Transaction Price Per Share: 0.00." This suggests that the shares were acquired through an employee stock option plan, which is a common practice in the industry to incentivize employees.

Impact

This acquisition may have implications for both Mottola Frank and Supernus, Inc. As the Senior Vice President and Chief Technical Operations Officer, Frank's ownership stake reflects a personal investment in the company's future. It may also serve to motivate other employees within the organization to engage more deeply with their roles, knowing that leadership is committed to their success.

What's Next

The filing does not say what happens next.